Trials / Unknown
UnknownNCT02488603
Decision Aids for Tamoxifen Treatment in Breast Cancer Patients
Utilization of Decision Aids for Tamoxifen Treatment in Breast Cancer Patients: A Randomized Controlled Trial.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 360 (estimated)
- Sponsor
- National Cancer Center, Korea · Other Government
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is an educational intervention study for breast cancer patients who undergo tamoxifen treatment. The purpose of the study is to assess the impact of decision aids (DA) on the patients' decision-making process, compliance on drug, and knowledge regarding tamoxifen treatment. Patients will randomly assign to DA group or conventional group. Both groups will have baseline questionnaire surveys before starting tamoxifen treatment, and 4 weeks later follow-up questionnaire surveys.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Decision aids (tamoxifen-related educational materials in brochure or mobile app) | Decision aids (tamoxifen-related educational materials in brochure or mobile app) |
| DRUG | tamoxifen |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2018-08-01
- First posted
- 2015-07-02
- Last updated
- 2015-07-02
Source: ClinicalTrials.gov record NCT02488603. Inclusion in this directory is not an endorsement.